
Genetic clues link higher caffeine levels to lower body fat and diabetes risk
A 2023 Mendelian randomization study using data from about 10,000 people found that genetically higher plasma caffeine concentrations are associated with lower BMI and fat mass, and a reduced risk of type 2 diabetes (about half of the effect mediated by BMI). There was no clear link to cardiovascular diseases. The authors note caffeine metabolism genes CYP1A2 and AHR influence caffeine levels, and suggest caffeine may boost thermogenesis and fat oxidation; however causal relationships aren’t proven and randomized trials are needed to confirm whether non-caloric caffeinated beverages could help reduce obesity or diabetes risk.









